IDEXX Laboratories, Inc. IDXX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 15.49% | 15.11% | 14.74% | 14.82% | 17.94% |
| Total Depreciation and Amortization | 10.75% | 14.76% | 10.63% | 14.88% | 7.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -87.01% | 24.20% | 81.97% | 148.13% | 960.37% |
| Change in Net Operating Assets | 488.91% | 65.25% | -47.89% | 294.38% | 65.22% |
| Cash from Operations | 11.78% | 86.90% | 11.89% | 35.77% | 82.82% |
| Capital Expenditure | 7.02% | 27.73% | -6.52% | -0.61% | -10.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 130.97% | -279.32% | -475.00% | 112.32% | -3,414.94% |
| Cash from Investing | -452.92% | 24.18% | -13.29% | 29.40% | -63.95% |
| Total Debt Issued | 63.71% | -104.24% | 89.93% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -38.24% | 89.92% | 152.48% | 34.81% | 920.22% |
| Repurchase of Common Stock | 53.25% | -2.37% | 11.16% | 3.33% | -8.74% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 35.90% | -96.33% | 35.99% | -52.80% | -7.67% |
| Foreign Exchange rate Adjustments | 71.55% | -100.51% | 64.93% | 99.75% | -111.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -98.62% | -676.12% | 116.46% | -37.93% | 146.87% |